Piramal Pharma Ltd
Piramal Pharma's Climate Target Data Preview
As of 2025, Piramal Pharma has disclosed 2 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 2 absolute reduction targets, signaling the company's commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Piramal Pharma's climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy/Paste is a PRO feature.  a | 2030 |
Absolute-based Target | Scope 3 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | 0000000 | 2030 |
Verified Sources Behind Piramal Pharma’s Climate Targets Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Piramal Pharma’s data sources below and access millions more through our Disclosure Search.
Insights into Piramal Pharma's Greenhouse Gas Emissions Pathways
As of 2025, Piramal Pharma has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint.a
Does Piramal Pharma have a target to reduce the emissions from its operations?
As of 2025, Piramal Pharma has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.a
Piramal Pharma's most ambitious operational target is to reduce these emissions by 42% by 2030, compared to a baseline of 142,422 Metric Tonnes of CO2 equivalent (mtCO2e) in 2022.a
As of 2025, Piramal Pharma is lagging behind on its operational emissions reduction target, having achieved 25.02% of the planned reduction.a
Piramal Pharma's Operational (Scope 1+2) Emissions Pathway
Does Piramal Pharma have a target to reduce the emissions from its value chain?
As of 2025, Piramal Pharma has set a target to reduce its value chain greenhouse gas (GHG) emissions, covering 1 out of the 15 Scope 3 categories defined by the GHG Protocol.a
Piramal Pharma's most ambitious value chain target is to reduce these emissions by 25% by 2030, compared to a baseline of 477,407 Metric Tonnes of CO2 equivalent (mtCO2e) in 2022.a
Instead of reducing value chain emissions, Piramal Pharma has increased them, with 2025 levels exceeding those of the 2022 baseline, placing the company well behind its reduction target.a